A Multi-Centre, Multi-National, Observational Post-Authorisation Safety Study to Document the Drug Utilisation of Samsca and to Collect Information on the Safety of Samsca When Used in Routine Medical Practice.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Apr 2013
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Adverse reactions; Therapeutic Use
- 30 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Nov 2011 Additional locations added as reported by ClinicalTrials.gov.
- 30 Oct 2010 New trial record